We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
-3.2%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$745B
AUM Growth
+$33.9B
Cap. Flow
+$45.4B
Cap. Flow %
6.09%
Top 10 Hldgs %
31.69%
Holding
14,193
New
1,741
Increased
5,205
Reduced
5,319
Closed
1,559

Top Sells

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$2.17B
2
AMZN icon
Amazon
AMZN
+$1.98B
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.79B
4
NVDA icon
NVIDIA
NVDA
+$1.18B
5
WFC icon
Wells Fargo
WFC
+$827M

Sector Composition

Rank Sector Weight
1 Technology 1.89%
2 Consumer Discretionary 1.29%
3 Communication Services 0.93%
4 Healthcare 0.89%
5 Financials 0.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SNMP
12351
DELISTED
Evolve Transition Infrastructure LP
SNMP
$40K ﹤0.01%
+1,264
New +$43.6K
STAB
12352
CALL
DELISTED
Statera Biopharma, Inc. Common Stock
STAB
$40K ﹤0.01%
+17,500
New +$66.3K
ONCS
12353
CALL
DELISTED
OncoSec Medical Incorporated
ONCS
$40K ﹤0.01%
+855
New +$43.3K
ASRT
12354
DELISTED
Assertio
ASRT
$39K ﹤0.01%
+2,904
New +$49.7K
PHIO icon
12355
PUT
Phio Pharmaceuticals
PHIO
$13.8M
$39K ﹤0.01%
180
-105
-37% -$21.9K
PLUR icon
12356
CALL
Pluri
PLUR
$17.9M
$39K ﹤0.01%
1,863
-26,162
-93% -$670K
SIFY
12357
Sify Technologies
SIFY
$1.05B
$39K ﹤0.01%
1,930
-4,481
-70% -$92.7K
ARAV
12358
DELISTED
Aravive, Inc. Common Stock
ARAV
$39K ﹤0.01%
10,570
-22,326
-68% -$95.3K
CNCE
12359
PUT
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$39K ﹤0.01%
11,800
-2,900
-20% -$10.2K
NBRV
12360
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$39K ﹤0.01%
+1,311
New +$37K
NES
12361
DELISTED
Nuverra Environmental Solutions, Inc. Common Stock
NES
$39K ﹤0.01%
+19,977
New +$43.9K
EVOK
12362
CALL
DELISTED
Evoke Pharma
EVOK
$38K ﹤0.01%
204
-1,470
-88% -$248K
NEWP
12363
New Pacific Metals
NEWP
$1.31B
$38K ﹤0.01%
+11,300
New +$42.5K
UBX
12364
CALL
DELISTED
Unity Biotechnology
UBX
$38K ﹤0.01%
1,280
+220
+21% +$7.76K
TGA
12365
DELISTED
Transglobe Energy Corp
TGA
$38K ﹤0.01%
+17,421
New +$31.2K
BXRX
12366
CALL
DELISTED
Baudax Bio, Inc. Common Stock
BXRX
$38K ﹤0.01%
48
-31
-39% -$27K
GNCA
12367
PUT
DELISTED
Genocea Biosciences, Inc.
GNCA
$38K ﹤0.01%
19,700
-41,700
-68% -$82K
CTIC
12368
CALL
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$38K ﹤0.01%
12,800
-215,600
-94% -$587K
FENG
12369
Phoenix New Media
FENG
$17.9M
$37K ﹤0.01%
4,803
+1,790
+59% +$14.6K
PVL
12370
CALL
Permianville Royalty Trust
PVL
$59.7M
$37K ﹤0.01%
19,100
-5,000
-21% -$9.22K
TK icon
12371
CALL
Teekay
TK
$1.17B
$37K ﹤0.01%
10,200
-60,400
-86% -$190K
NIXX
12372
Nixxy Inc
NIXX
$20.4M
$37K ﹤0.01%
+760
New +$48.8K
PUCKW
12373
DELISTED
Goal Acquisitions Corp. Warrant
PUCKW
$37K ﹤0.01%
+62,745
New +$39.5K
VINO
12374
PUT
DELISTED
Gaucho Group Holdings, Inc. Common Stock
VINO
$37K ﹤0.01%
+10
New +$42.1K
IMV
12375
CALL
DELISTED
IMV Inc. Common Shares
IMV
$37K ﹤0.01%
+2,200
New +$38K

Similar funds

Jeff Yass's Q3 2021 Portfolio in Review

As of Q3 2021, Jeff Yass held 14,193 positions worth $745B, up 4.8% from $712B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Jeff Yass deployed $45.4B of net new capital in Q3 2021, opening 1,741 new positions and adding to 5,205 existing holdings. Its largest new stake was InMode: 613,660 shares worth $48.9M.

By sector, the portfolio is most concentrated in Technology at 1.9% of assets, down from 1.9% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was Walt Disney, an estimated $2.17B trimmed.

  • Jeff Yass's largest Q3 2021 buy was InMode: 613,660 shares worth $48.9M.
  • Jeff Yass added most to Zoom in Q3 2021, an estimated $834M increase.
  • Jeff Yass's biggest Q3 2021 reduction was Walt Disney, cutting an estimated $2.17B.
  • Jeff Yass fully exited PRA Health Sciences, Inc. in Q3 2021, selling an estimated $103M.
  • Jeff Yass's ten largest holdings make up 32% of its $745B portfolio in Q3 2021.
  • Jeff Yass opened 1,741 new positions and closed 1,559 in Q3 2021.
  • Jeff Yass's portfolio value rose 4.8% quarter-over-quarter to $745B.

Based on Susquehanna International Group's 13F filing for Q3 2021, filed 15 Nov 2021.